Determinants of Cardiovascular Events After Simultaneous Pancreas Kidney Transplantation: A Retrospective Cohort

Steve Khalil1, Zahidul Mondal2, Neeraj Singh2

  • 1Internal Medicine and Nephrology, Rutgers Robert Wood Johnson Medical School, New Brunswick, USA.

Cureus
|July 8, 2026
PubMed

Insights

Cardiovascular events after simultaneous pancreas-kidney transplants are linked to early kidney function. Lower estimated glomerular filtration rate (eGFR) in the first month post-transplant increases the risk of major adverse cardiovascular events (MACE).

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation Immunology

Background:

  • Simultaneous pancreas-kidney transplantation (SPK) offers metabolic and renal benefits.
  • Cardiovascular complications are a significant cause of morbidity and mortality post-SPK.
  • Factors influencing major adverse cardiovascular events (MACE) in SPK recipients require further characterization.

Purpose of the Study:

  • To identify factors associated with post-transplant MACE in adult SPK recipients.
  • To investigate the relationship between early kidney allograft function and cardiovascular outcomes.
  • To evaluate the association of the triglyceride-glucose (TyG) index with MACE.

Main Methods:

  • Retrospective cohort analysis of 80 adult SPK recipients (2018-2025).
  • Primary endpoint: composite MACE (myocardial infarction, stroke, cardiovascular death, heart failure, arrhythmia).
  • Multivariable logistic regression including one-month estimated glomerular filtration rate (eGFR) and kidney cold ischemic time.

Main Results:

  • MACE occurred in 17.5% of recipients.
  • Higher one-month eGFR was associated with lower odds of MACE (aOR 0.61 per 10 mL/min/1.73 m² increase; P=0.040).
  • Longer kidney cold ischemic time showed a borderline association with MACE (aOR 1.28 per hour; P=0.057).
  • The triglyceride-glucose index was not significantly associated with MACE.

Conclusions:

  • Lower early kidney allograft function is associated with increased odds of post-transplant cardiovascular events in SPK recipients.
  • The triglyceride-glucose index is not an independent predictor of MACE in this population.
  • Findings are exploratory due to a limited number of events and require validation in larger cohorts.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...